Last week a multiple myeloma listserv member posted a ScienceDaily article that initially puzzled me. The article (http://tinyurl.com/2k3acf) begins: “Scientists report that a protein best known as a common marker of inflammation plays a key role in the progression of human cancer. The research, published by Cell Press in the September issue of the journal Cancer Cell, implicates C-reactive protein (CRP) as a potential target for cancer treatment.” Well, that didn’t seem like breaking news to me. One of my regular blood tests measures my serum levels of CRP, and I know that it’s a myeloma marker. But then I read the showstopper: “These results provide strong evidence that CRP is not just a marker for MM but is a critical regulator of myeloma cell survival.”

http://margaret.healthblo...